All PlansCoverageMedium impact
Upcoming Policies effective February 2, 2026
Blue Cross and Blue Shield of Minnesota·MN · Hematology, Nuclear Medicine, Oncology +2 more·Medical Policy
Effective date
Feb 2, 2026
We identified it
Jun 20, 2026
Summary
Blue Cross Minnesota revised policies for hematopoietic stem cell transplantation, electroconvulsive therapy (ECT), and PET scanning for oncology, updating medical necessity criteria and coverage determinations. These changes will affect prior authorization requirements and documentation standards for these specialized procedures.
Action Required
Before February 2, 2026: Review updated medical necessity criteria for hematopoietic stem cell transplantation, ECT, and oncologic PET scans. Update prior authorization workflows to reflect new coverage requirements. Ensure providers document specific severity criteria for ECT (age 12+, severe illness indicators, medication trial failures). Note that autologous stem cell transplants and repeat transplants are now experimental/investigative. Update billing system notes for these policy changes.